OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
Go back to OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19| OPKO HEALTH, Inc. (NASDAQ: OPK) | Delayed: 1.49 +0.03 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.46 | 52 Week High | $11.85 | |||
| Open | $1.46 | 52 Week Low | $7.12 | |||
| Day High | $1.52 | P/E | N/A | |||
| Day Low | $1.46 | EPS | $-0.30 | |||
| Volume | 2,371,140 | |||||
